Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 2—February 2009

Research

Epidemiology of Vibrio parahaemolyticus Outbreaks, Southern Chile

Erika Harth1, Luis Matsuda, Cristina Hernández, Maria L. Rioseco, Jaime Romero, Narjol González-Escalona, Jaime Martínez-Urtaza, and Romilio T. EspejoComments to Author 
Author affiliations: Universidad de Chile, Santiago, Chile (E. Harth, L. Matsuda, J. Romero, R.T. Espejo); Secretaría Regional Ministerial de Salud, Puerto Montt, Chile (C. Hernández); Hospital Regional de Puerto Montt, Puerto Montt (M.L. Rioseco); Food and Drug Administration, College Park, Maryland, USA (N. González-Escalona); Universidad de Santiago de Compostela, Santiago de Compostela, Spain (J. Martínez-Urtaza); 1Current affiliation: Helmholtz Centre of Infection Research, Braunschweig, Germany.

Main Article

Table 1

Properties of Vibrio parahaemolyticus clinical isolates from Puerto Montt, Chile, summer 2007*

Isolate tlh tdh trh orf8 ToxRS/new Serotype DGREA group MLST ST†
PMC50.7, 51.7, 41.7, 72.7, 1.7, 15.7, 16.7 + + + + O3:K6 VpKX 3
PMC55.7, 56.7, 58.7, 28.7, 44.7, 73.7, 14.7, 18.7 + + + + O3:K59 VpKX ND
PMC29.7, 42.7, 70.7, 11.7, 19.7 + + + + O3:K6,59 VpKX ND
PMC59.7, 63.7, 64.7, 65.7, 66.7, 20.7, 22.7 + + + + ND VpKX ND
PMC38.7, 47.7, 57.7, 68.7 + + O10:K20 38.7 63
PMC60.7, 25.7, 26.7, 27.7 + + + O1:KUT 60.7 64
PMC53.7 + O3:K59 1.5 28
PMC75.7 + O1:KUT 75.7 65

*Isolates with an undetermined serotype are in boldface. orf, open reading frame; DGREA, direct genome restriction enzyme analysis; MLST, multilocus sequence typing; ST, sequence type; ND, not determined.
†Sequences are available from http://pubmlst.org/vparahaemolyticus.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO